for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Allergan - Pfizer deal in doubt

Posted

Pfizer is leaning towards abandoning its $160 billion merger deal with Allergan. If the deal collapses, analysts say, both companies could pursue other acquisitions. Fred Katayama reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up